Acrivon Therapeutics
ACRV
#9762
Rank
S$63.28 M
Marketcap
S$2.01
Share price
-0.63%
Change (1 day)
-71.87%
Change (1 year)

Acrivon Therapeutics (ACRV) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$21.19 Million

According to Acrivon Therapeutics's latest financial reports the company's total liabilities are S$21.19 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Acrivon Therapeutics - Total liabilities on balance sheet (from 2021 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$26.91 M19.39%
2023-12-31S$22.54 M56.42%
2022-12-31S$14.41 M-91.82%
2021-12-31S$0.17 B1157.33%
2020-12-31S$14.02 M